Department of Radiation Oncology, Northern Sydney Cancer Centre, Royal North Shore Hospital, Sydney, NSW, Australia.
AIMS: The debate on the funding and availability of cytotoxic drugs raises questions about the contribution of curative or adjuvant cytotoxic chemotherapy to survival in adult cancer patients.
MATERIALS AND METHODS: We undertook a literature search for randomised clinical trials reporting a 5-year survival benefit attributable solely to cytotoxic chemotherapy in adult malignancies.
RESULTS: The overall contribution of curative and adjuvant cytotoxic chemotherapy to 5-year survival in adults was estimated to be 2.3% in Australia and 2.1% in the USA.
CONCLUSION: As the 5-year relative survival rate for cancer in Australia is now over 60%, it is clear that cytotoxic chemotherapy only makes a minor contribution to cancer survival. To justify the continued funding and availability of drugs used in cytotoxic chemotherapy, a rigorous evaluation of the cost-effectiveness and impact on quality of life is urgently required.
source: PMID: 15630849 [PubMed]
Recommendations WCRF
WCRF glossary
Food & nutrition
Health Survey USA 2007
Science orthodox treatments
Health effects of fungi
Controversy Colloidal Silver
Silver Hydrosol Valuable Role
Video Dr. John HumistonVideo Doug KaufmannVideo Jim Humble Video Dr MercolaDr Mercola's No-Grain DietVideo virus bacteria and fungiDr Simoncini in Los Angeles
Interview with Dr. Apsley
PromotoolsYour suggestionUnconventional medics needed
Cancer categories CandidaCandida symptomsFungi Candida dietVitaminsChemotherapy statsPsoriasisArthtritisHerxheimerSkin cancerYeast overgrowth
录影以副标题knowthecauseimvamercola
